Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Organon & Co. Common Stock
(NY:
OGN
)
7.060
-2.100 (-22.93%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
34,936,500
Open
7.250
Bid (Size)
7.040 (8)
Ask (Size)
7.050 (4)
Prev. Close
9.160
Today's Range
6.800 - 7.640
52wk Range
6.800 - 19.05
Shares Outstanding
253,545,051
Dividend Yield
1.13%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Kaplan Fox is Investigating Organon & Co. (OGN) Following an Announcement of Findings of an Audit Committee Investigation and CEO Resignation
October 27, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Kaplan Fox is Investigating Organon & Co. (OGN) Following an Announcement of Findings of an Audit Committee Investigation and CEO Resignation
October 27, 2025
Via
TheNewswire.com
Performance
YTD
-52.8%
-52.8%
1 Month
-31.8%
-31.8%
3 Month
-29.2%
-29.2%
6 Month
-44.5%
-44.5%
1 Year
-59.6%
-59.6%
More News
Read More
Which stocks are moving on Monday?
October 27, 2025
Via
Chartmill
Keep an eye on the top gainers and losers in Monday's session.
October 27, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
October 27, 2025
Via
Benzinga
Gold Falls 3%; Carter's Shares Gain After Q3 Earnings
October 27, 2025
Via
Benzinga
Which stocks are gapping on Monday?
October 27, 2025
Via
Chartmill
These stocks are moving in today's pre-market session
October 27, 2025
Via
Chartmill
Organon CEO Kevin Ali Resigns Amid Audit Probe Into Wholesaler Sales Practices
October 27, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 27, 2025
Via
Benzinga
Organon Appoints Company Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation
October 27, 2025
From
Organon
Via
Business Wire
3 Small-Cap Stocks We Steer Clear Of
October 21, 2025
Via
StockStory
1 Profitable Stock Worth Your Attention and 2 Facing Challenges
October 16, 2025
Via
StockStory
DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know
October 10, 2025
Via
StockStory
Topics
Economy
Government
World Trade
Q2 Earnings Highs And Lows: Organon (NYSE:OGN) Vs The Rest Of The Branded Pharmaceuticals Stocks
October 08, 2025
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
3 Reasons to Avoid OGN and 1 Stock to Buy Instead
October 06, 2025
Via
StockStory
Topics
Government
Stocks
World Trade
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
September 30, 2025
Via
MarketMinute
Topics
Government
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
September 30, 2025
Via
MarketMinute
Topics
Economy
Government
World Trade
AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know
September 30, 2025
Via
StockStory
Topics
Government
1 Surging Stock Worth Your Attention and 2 We Avoid
September 29, 2025
Via
StockStory
Topics
Initial Public Offering
Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers
September 27, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Why Organon (OGN) Stock Is Trading Up Today
September 11, 2025
Via
StockStory
Topics
Artificial Intelligence
Economy
Initial Public Offering
3 Stocks Under $50 We Find Risky
September 11, 2025
Via
StockStory
US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
September 02, 2025
From
Organon & Co.
Via
Business Wire
3 Cash-Producing Stocks with Warning Signs
August 28, 2025
Via
StockStory
Frequently Asked Questions
Is Organon & Co. Common Stock publicly traded?
Yes, Organon & Co. Common Stock is publicly traded.
What exchange does Organon & Co. Common Stock trade on?
Organon & Co. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Organon & Co. Common Stock?
The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange
What is the current price of Organon & Co. Common Stock?
The current price of Organon & Co. Common Stock is 7.060
When was Organon & Co. Common Stock last traded?
The last trade of Organon & Co. Common Stock was at 10/27/25 07:00 PM ET
What is the market capitalization of Organon & Co. Common Stock?
The market capitalization of Organon & Co. Common Stock is 1.79B
How many shares of Organon & Co. Common Stock are outstanding?
Organon & Co. Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.